You are viewing an incomplete version of our website. Please click to reload the website as full version.

Quinoid Dihydropteridine Reductase (QDPR) (C-Term) Peptide

Details for Product No. ABIN698468, Supplier: Log in to see
Protein Name
  • QDPR
  • qdpr
  • MGC131372
  • DDBDRAFT_0168923
  • DDBDRAFT_0237752
  • DDB_0168923
  • DDB_0237752
  • CG4665
  • DHPR
  • Dmel\\CG4665
  • 2610008L04Rik
  • D5Ertd371e
  • Dhpr
  • PKU2
  • SDR33C1
Protein Region
C-Term
Source
Synthetic
Peptide Type
Synthetic
Application
Blocking Peptide (BP)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Immunogen Synthetic peptide
Specificity The synthetic peptide sequence used to generate the antibody AP8841b was selected from the C-term region of human QDPR. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Background QDPR is the enzyme dihydropteridine reductase, which catalyzes the NADH-mediated reduction of quinonoid dihydrobiopterin. This enzyme is an essential component of the pterin-dependent aromatic amino acid hydroxylating systems.
Restrictions For Research Use only
Storage 4
Storage Comment Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Expiry Date 6 months
Background publications Schnetz-Boutaud, Anderson, Brown et al.: "Examination of tetrahydrobiopterin pathway genes in autism." in: Genes, brain, and behavior, Vol. 8, Issue 8, pp. 753-7, 2009 (PubMed).